ArticleThe Lancet regional health. Western Pacific2024

Clinical utility of the treatment eligibility score HEPSANET for chronic hepatitis B in Asia.

Jian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.